Page 1

A polyp is an abnormal growth of tissue projecting from a mucous membrane commonly found in the colon, stomach, nose, ear, sinus, urinary bladder, uterus etc. although they may occur elsewhere in the body where mucous membranes exist. Most polyps are benign or noncancerous while a few are premalignant. Premalignant polyps can be a trigger factors for cancer and in general, the larger a polyp, the greater the risk of cancer, especially with premalignant polyps. Most polyps have no symptoms and screening is the only reliable measure to detect them. Symptoms when evident are irregular periods and vaginal bleeding in women, dysmenorrhea, pain, diarrhoea, constipation, nausea, vomiting etc. depending on the location of the polyp. Screening is the most important driver for the Global Polyp Market. The U.S. Department of Health and Human Services estimates that in 2016, an estimated 134,490 people in the United States were diagnosed with colorectal cancer and 49,190 people died from contracting it. The market drivers for polyp market are increasing geriatric population, growing screening, rising awareness, cancer causing potential of polyps etc. The market restraints are risks such as bleeding and infection during surgery, low healthcare expenditure in developing regions, costs considerations especially for minimally invasive surgeries, no symptoms of most polyps, personal or family history of polyps etc. Global Polyps Market Players Key players profiled in the report are Millennium Surgical Corp, Black Smith Surgical, B. Braun Melsungen AG, Medtronic, Cook Medical, Endo Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan Inc., Sun Pharmaceuticals and others. Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4176 . Segmentation The Global Polyps Market has been segmented on the basis of stage, types, diagnosis, surgery and end users. Based on stage, the market has been segmented as benign and pre-malignant. Based on types, the market has been segmented as digestive polyps, endometrial polyp, cervical polyp, nasal polyps, laryngeal polyps and pre-malignant. Based on diagnosis, the market has been segmented as occult blood and stool test, colonoscopy, sigmoidoscopy, double contrast barium enema, computed tomography and others. Based on treatment, the market has been segmented as drugs which is further sub segmented into hormonal drugs, pain killers and others and surgery which is further sub segmented into polypectomy, minimally invasive surgery, colon and rectum removal and others. Based on the end users, the market has been segmented as hospitals & clinics, academic and research and others. Regional Analysis The Americas account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new technology in the US drives the global polyps market. Also, concentration of major research companies and cancer research sector in the developed countries of this region is adding fuel to the market growth. Europe is the second largest market in the world due to high income and healthcare penetration. Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period. Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development. Table of Contents 1. Introduction


1.1 Definition 1.2 Scope of Study 1.2.1 Research Objective 1.2.2 Assumptions & Limitations 1.2.2.1 Assumptions 1.2.2.2 Limitations 1.3 Market Structure 2. Research Methodology 2.1 Research Process 2.2 Primary Research 2.3 Secondary Research 3. Market Dynamics 3.1 Drivers 3.2 Restraints 3.3 Opportunities 3.4 Macroeconomic Indicators 4. Market Factor Analysis 4.1 Porters Five Forces Model 4.2 Bargaining Power of Suppliers 4.3 Bargaining Power of Buyers 4.4 Threat of New Entrants 4.5 Threat of Substitutes 4.6 Intensity of Rivalry 5. Global Polyps Market, By Stage ‌ Continued Ask Question to Expert @ https://www.marketresearchfuture.com/enquiry/4176 . About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers


Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com

Polyps Market 2018 – Global Industry Size, Share, Analysis, Trend & Future Strategic Planning  

The Global Polyps Market has been segmented on the basis of stage, types, diagnosis, surgery and end users.

Polyps Market 2018 – Global Industry Size, Share, Analysis, Trend & Future Strategic Planning  

The Global Polyps Market has been segmented on the basis of stage, types, diagnosis, surgery and end users.

Advertisement